Why Bio-Rad Laboratories Stock Slipped by More Than 3% on Thursday [Yahoo! Finance]
Bio-Rad Laboratories, Inc. Class B (BIO.B)
US:NYSE Investor Relations:
bio-rad.com/en-us/corporate/investor-relations
Company Research
Source: Yahoo! Finance
It beat on both the top and bottom lines, but growth rates were low. 10 stocks we like better than Bio-Rad Laboratories › Healthcare diagnostics product supplier Bio-Rad Laboratories (NYSE: BIO) notched twin beats in its just-released third quarter, but that wasn't enough for a choosy stock market. Investors sold out of the company's shares in the wake of that earnings report to leave it with an over 3% loss on Thursday. This was a steeper fall than the 0.9% decline of the benchmark S&P 500 index. Modest improvements Bio-Rad's Q3 saw the company book $653 million in revenue, which was very modestly (0.5%) higher on a year-over-year basis. Net income not according to generally accepted accounting principles ( GAAP ) rose at a slightly higher rate, advancing by 8% to just under $61 million. On a per-share basis, that non-GAAP (adjusted) bottom line figure was $2.26. Image source: Getty Images. Although Bio-Rad didn't post explosive growth, those numbers were high enough to
Show less
Read more
Impact Snapshot
Event Time:
BIO.B
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIO.B alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIO.B alerts
High impacting Bio-Rad Laboratories, Inc. Class B news events
Weekly update
A roundup of the hottest topics
BIO.B
News
- A Look At The Intrinsic Value Of Bio-Rad Laboratories, Inc. (NYSE:BIO) [Yahoo! Finance]Yahoo! Finance
- Investors in Bio-Rad Laboratories (NYSE:BIO) have unfortunately lost 47% over the last five years [Yahoo! Finance]Yahoo! Finance
- Vector Purification Research Report 2025-2035: 100+ Products, 1,000+ Clinical Trials and Rising Demand for Adenoviral and Lentiviral Therapies Drive Global Growth [Yahoo! Finance]Yahoo! Finance
- Bio-Rad Laboratories, Inc. Co-Founder and Director Emeritus Alice Schwartz Passes Away [Yahoo! Finance]Yahoo! Finance
- Non-Viral Transfection Reagents Market Industry Trends and Forecasts to 2035: Patents, Partnerships, and Big Pharma Initiatives Accelerate Non-Viral Transfection Reagents Market Growth [Yahoo! Finance]Yahoo! Finance